# Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis

> **NCT07754617** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Rhode Island Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Schistosomiasis
- Schistosoma Mansoni
- Liver Fibrosis
- Portal Hypertension

## Interventions

- **DRUG:** Praziquantel 40 mg/kg per dose given once annually
- **DRUG:** Praziquantel 40 mg/kg given three times per year

## Key facts

- **NCT ID:** NCT07754617
- **Lead sponsor:** Rhode Island Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11
- **Primary completion:** 2029-11
- **Final completion:** 2029-11
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-08-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07754617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07754617, "Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07754617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*